WPI 2281 Pill - green round
Pill with imprint WPI 2281 is Green, Round and has been identified as Zolpidem Tartrate Extended-Release 6.25 mg. It is supplied by Watson Laboratories, Inc.
Zolpidem is used in the treatment of Insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 6.25 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 2281
Zolpidem Tartrate Extended-Release
- Imprint
- WPI 2281
- Strength
- 6.25 mg
- Color
- Green
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-2281
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer,
FD&C Blue No. 1,
FD&C Blue No. 2,
hydroxypropyl cellulose,
hypromelloses,
ferrosoferric oxide,
ferric oxide yellow,
magnesium stearate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
microcrystalline cellulose,
polyethylene glycol,
propylene glycol,
sodium bicarbonate,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide,
triethyl citrate,
polysorbate 80
Note: Inactive ingredients may vary.
More about zolpidem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,051)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- Breastfeeding
- En español
Patient resources
Other brands
Ambien, Ambien CR, Zolpimist, Intermezzo, Edluar
Professional resources
- Zolpidem monograph
- Zolpidem (FDA)
- Zolpidem Capsule (FDA)
- Zolpidem Extended Release (FDA)
- Zolpidem Sublingual (FDA)
Other brands
Ambien, Ambien CR, Zolpimist, Intermezzo, Edluar
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.